SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Orchid Pharma - Quaterly Results

12 Aug 2024 Evaluate
The Sales for the quarter ended June 2024 of Rs. 2444.06 millions rose by 33.61% from Rs. 1829.20 millions.The company almost doubled its revenue to Rs. 291.03 millions  from Rs. 107.75 millions in the quarter ended June 2024.Operating profit surged to 410.20 millions from the corresponding previous quarter of 240.28 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 2444.06 1829.20 33.61 2444.06 1829.20 33.61 8193.68 6658.98 23.05
Other Income 77.72 18.86 312.09 77.72 18.86 312.09 303.89 194.30 56.40
PBIDT 410.20 240.28 70.72 410.20 240.28 70.72 1410.70 1030.49 36.90
Interest 34.73 55.45 -37.37 34.73 55.45 -37.37 163.28 322.26 -49.33
PBDT 375.47 184.83 103.14 375.47 184.83 103.14 1247.42 1100.33 13.37
Depreciation 84.44 77.08 9.55 84.44 77.08 9.55 332.19 547.87 -39.37
PBT 291.03 107.75 170.10 291.03 107.75 170.10 915.23 552.46 65.66
TAX 0.00 0.00 0.00 0.00 0.00 0.00 -32.26 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -32.26 0.00 0.00
PAT 291.03 107.75 170.10 291.03 107.75 170.10 947.49 552.46 71.50
Equity 507.19 507.19 0.00 507.19 507.19 0.00 507.19 408.16 24.26
PBIDTM(%) 16.78 13.14 27.77 16.78 13.14 27.77 17.22 15.48 11.25

Orchid Pharma Share Price

544.95 -14.25 (-2.55%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×